Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: A cross-sectional survey

References

• Zasler ND, Martelli Jacobs HE. Neurobehavioral disorders. Handbook of Clinical Neurology 2013;110:377–388
   PubMedGoogle Scholar
• Riggio S. Traumatic brain injury and its neurobehavioral sequelae. Psychiatric Clinics of North America 2010;33:807–819
   PubMed Web of Science ®Google Scholar
• Angelelli P, Paolucci S, Bivona U, Piccardi L, Ciurli P, Cantagallo A, Antonucci G, Fasotti L, Di Santantonio A, Grasso MG, et al. Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatrica Scandiavica 2004;110:55–63
   PubMed Web of Science ®Google Scholar
• Ciurli P, Formisano R, Bivona U, Cantagallo A, Angelelli P. Neuropsychiatric disorders in persons with severe traumatic brain injury: prevalence, phenomenology, and relationship with demographic, clinical, and functional features. Journal of Head Trauma Rehabilitation 2011;26:116–126
   PubMed Web of Science ®Google Scholar
• Wheaton P, Mathias JL, Vink R. Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: a meta-analysis. Journal of Clinical Psychopharmacology 2011;31:745–757
   PubMed Web of Science ®Google Scholar
• Writer BW, Schillerstrom JE. Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: a critical review. Journal of Neuropsychiatry & Clinical Neurosciences 2009;21:362–370
   Google Scholar
• Warden DL, Gordon B, McAllister TW, Silver JM, Barth JT, Bruns J, Drake A, Gentry T, Jagoda A, Katz DI, et al. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. Journal of Neurotrauma 2006;23:1468–1501
   PubMed Web of Science ®Google Scholar
• Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury–a state-of-the-art review. Journal of Rehabilitation Research & Development 2009;46:851–879
   PubMed Web of Science ®Google Scholar
• Fann JR, Hart T, Schomer KG. Treatment for depression after traumatic brain injury: a systematic review. Journal of Neurotrauma 2009;26:2383–2402
   PubMed Web of Science ®Google Scholar
• Barker-Collo S, Starkey N, Theadom A. Treatment for depression following mild traumatic brain injury in adults: a meta-analysis. Brain Injury 2013;27:1124–1133
   PubMed Web of Science ®Google Scholar
• Paranthaman R, Baldwin RC. Treatment of psychiatric syndromes due to cerebrovascular disease. International Review of Psychiatry 2006;18:453–470
   PubMed Web of Science ®Google Scholar
• Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, Knapp P. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008860. DOI: 10.1002/14651858.CD008860.pub2
   Google Scholar
• Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003299. DOI: 10.1002/14651858.CD003299.pub2
   Google Scholar
• Levy M, Berson A, Cook T, Bollegala N, Seto E, Tursanski S, Kim J, Sockalingam S, Rajput A, Krishnadev N, et al. Treatment of agitation following traumatic brain injury: a review of the literature. NeuroRehabilitation 2005;20:279–306
   PubMed Web of Science ®Google Scholar
• Whyte J. Pharmacologic treatment of cognitive and behavioral sequelae of traumatic brain injury: practicing in the absence of strong evidence. European Journal of Physical Rehabilitation Medicine 2010;46:557–562
   Google Scholar
• Gupta SK, Nayak RP. Off-label use of medicine: perspective of physicians, patients, pharmaceutical companies and regulatory authorities. Journal of Pharmacology & Pharmacotherapy 2014;5:88–92
   PubMedGoogle Scholar
• Stafford RS. Off-label use of drugs and medical devices: a review of policy implications. Clinical Pharmacology & Therapeutics 2012;91:920–925
   Google Scholar
• Largent EA, Miller FG, Pearson SD. Going off-label without venturing off-course: evidence and ethical off-label prescribing. Archives of Internal Medicine 2009;169:1745–1747
   PubMed Web of Science ®Google Scholar
• Ghinea N, Lipworth W, Kerridge I, Day R. No evidence or no alternative? Taking responsibility for off-label prescribing. Internal Medicine Journal 2012;42:247–251
   PubMed Web of Science ®Google Scholar
• Long D, Watts C. Off-label use of drugs and devices: role of medical professionals in the establishment of parameters for their use. Neurosurgery 2013;72:1014–1020
   Google Scholar
• Frattarelli DA, Galinkin JL, Green TP, Johnson TD, Neville KA, Paul IM, Van Den Anker JN. Off-label use of drugs in children. Pediatrics 2014;133:563–567
   PubMed Web of Science ®Google Scholar
• Stafford RS. Off-label use of drugs and medical devices: a review of policy implications. Clinical Pharmacology & Therapeutics 2012;91:920–925
   Google Scholar
• Stephenson A, Anderson GM, Rochon P. Off-label prescribing in older people: the need for increased awareness and caution. Drugs & Aging 2012;29:435–436
   Google Scholar
• Italian Society for Physical and Rehabilitation Medicine (Società Italiana di Medicina Fisica e Riabilitazione. Consensus Conference 2010. Italy: Salsomaggiore Terme; 2010. Available online at: http://www.consensusconferencegca.com/assets/files/slide/GRUPPO_5_MENOMAZIONI%20COGNIT_COMPOR.pdf, (in Italian), accessed 14 October 2013
   Google Scholar
• Janzen S, McIntyre A, Meyer M, Sequeira K, Teasell R. The management of agitation among inpatients in a brain injury rehabilitation unit. Brain Injury 2014;28:318–322
   PubMed Web of Science ®Google Scholar
• Arciniegas DB, Wortzel HS. Emotional and behavioral dyscontrol after traumatic brain injury. Psychiatric Clinics of North America 2014;37:31–53
   PubMed Web of Science ®Google Scholar
• Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Journal of the American Medical Association 2011;306:1359–1369
   PubMed Web of Science ®Google Scholar
• Knottnerus AM, Turner-Stokes T, van de Weg FB, Heijnen L, Lankhorst GJ, Turner-Stokes L. Diagnosis and treatment of depression following acquired brain injury: a comparison of practice in the UK and the Netherlands. Clinical Rehabilitation 2007;21:805–811
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, MacWalter R. Use of antidepressant medication following acquired brain injury: concise guidance. Clinical Medicine 2005;5:268–274
   Google Scholar
• Pangilinan PH, Giacoletti-Argento A, Shellhaas R, Hurvitz EA, Hornyak JE. Neuropharmacology in pediatric brain injury: a review. Physical Medicine & Rehabilitation 2010;2:1127–1140
   Google Scholar
• Wolffbrandt MM, Poulsen I, Engberg AW, Hornnes N. Occurrence and severity of agitated behavior after severe traumatic brain injury. Rehabilitation Nursing 2013;38:133–141
   PubMed Web of Science ®Google Scholar
• Baguley IJ, Cooper J, Felmingham K. Aggressive behavior following traumatic brain injury: how common is common? Journal of Head Trauma Rehabilitation 2006;21:45–56
   PubMed Web of Science ®Google Scholar